NovaBridge Biosciences (NBP) Goodwill (2018 - 2022)
NovaBridge Biosciences (NBP) has disclosed Goodwill for 3 consecutive years, with $22.9 million as the latest value for Q4 2022.
- On a quarterly basis, Goodwill fell 10.11% to $22.9 million in Q4 2022 year-over-year; TTM through Dec 2022 was $22.9 million, a 10.11% decrease, with the full-year FY2022 number at $24.2 million, down 4.78% from a year prior.
- Goodwill was $22.9 million for Q4 2022 at NovaBridge Biosciences, down from $25.4 million in the prior quarter.
- In the past five years, Goodwill ranged from a high of $25.4 million in Q4 2021 to a low of $22.9 million in Q4 2022.
- A 3-year average of $23.9 million and a median of $23.5 million in 2018 define the central range for Goodwill.
- Biggest YoY gain for Goodwill was 10.11% in 2022; the steepest drop was 10.11% in 2022.
- NovaBridge Biosciences' Goodwill stood at $23.5 million in 2018, then increased by 8.14% to $25.4 million in 2021, then dropped by 10.11% to $22.9 million in 2022.
- Per Business Quant, the three most recent readings for NBP's Goodwill are $22.9 million (Q4 2022), $25.4 million (Q4 2021), and $23.5 million (Q4 2018).